Rozanolixizumab for Myasthenia Gravis: a breakthrough treatment and future prospects. [PDF]
Matic A, Bril V.
europepmc +1 more source
ABSTRACT Background & Aims HVPG is the gold standard for the diagnosis of clinically significant portal hypertension (CSPH), a condition associated with the risk of developing hepatic decompensation events. However, HVPG is an indirect method to measure portal pressure, and its application in the pre‐sinusoidal form of portal hypertension (PH), as in ...
Francesco Santopaolo+12 more
wiley +1 more source
Case of Myasthenia Gravis, with Affection of the Larynx and Soft Palate
E. D. D. Davis
openalex +1 more source
Unusual presentations of myasthenia gravis and misdiagnosis. [PDF]
Oguz-Akarsu E+5 more
europepmc +1 more source
To the casuistry of myasthenia (myasthenia gravis)
Alida-Elizaveta G. Shuler
openalex +2 more sources
Effectiveness of Immunosuppressive Therapy in Preventing the Progression of Ocular Myasthenia Gravis to Generalized Myasthenia Gravis: A Systematic Review and Meta-Analysis. [PDF]
Nall S+7 more
europepmc +1 more source
Risk of Exacerbation and Level of Healthcare Resource Utilization in Myasthenia Gravis Assessed by Myasthenia Gravis Activities of Daily Living Score. [PDF]
Ting A+6 more
europepmc +1 more source
DETERMINATION OF NEOSTIGMINE AND PYRIDOSTIGMINE IN THE URINE OF PATIENTS WITH MYASTHENIA GRAVIS [PDF]
P T Nowell, Carol A. Scott, A. S. Wilson
openalex +1 more source
Assessing therapeutic decisions in generalized myasthenia gravis: Study protocol. [PDF]
Gutiérrez-Gutiérrez G+13 more
europepmc +1 more source